Valuation: Star Combo Pharma Limited

Market Cap 18.91M 13.3M 11.92M 10.96M 9.93M 18.56M 1.26B 131M 52.47M 665M 49.93M 48.87M 2.1B P/E 2025
4.58x
P/E 2026 46.2x
Enterprise Value 5.09M 3.58M 3.21M 2.95M 2.67M 5M 340M 35.19M 14.13M 179M 13.44M 13.16M 564M EV / Sales 2025
0.15x
EV / Sales 2026 0.19x
Free-Float
8.75%
Yield 2025
2.74%
Yield 2026 2.19%
1 month+7.69%
3 months+7.69%
6 months-36.36%
Current year-46.15%
1 week 0.14
Extreme 0.14
0.14
1 month 0.13
Extreme 0.13
0.14
Current year 0.11
Extreme 0.11
0.28
1 year 0.11
Extreme 0.11
0.28
3 years 0.1
Extreme 0.1
0.28
5 years 0.09
Extreme 0.09
0.35
10 years 0.09
Extreme 0.09
2.03
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/06/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 71 01/01/2018
Director/Board Member - 01/01/2004
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-33.33%+27.27% 13.3M
+1.15%+2.87%+28.54%+67.38% 32.32B
-1.21%+2.56%+23.19%+67.96% 27.38B
+4.82%+2.43%-39.12%+525.99% 22.57B
+0.86%+1.56%-37.28%-11.87% 17.68B
+0.65%+4.21%-5.76% - 17.12B
+1.30%-0.57%-35.05%+34.49% 12.79B
+1.90%+0.63%+29.35% - 12.11B
+2.03%-3.76%-12.39%+193.91% 9.65B
+2.21%-2.92%-36.86%+10.14% 8.56B
Average +1.37%+0.70%-11.87%+114.41% 16.02B
Weighted average by Cap. +1.36%+1.60%-3.82%+138.21%

Financials

2025 2026
Net sales 27.81M 19.57M 17.52M 16.12M 14.61M 27.3M 1.86B 192M 77.16M 977M 73.43M 71.87M 3.08B 23.57M 16.58M 14.85M 13.66M 12.38M 23.14M 1.57B 163M 65.4M 828M 62.24M 60.92M 2.61B
Net income 5.25M 3.69M 3.31M 3.04M 2.76M 5.15M 351M 36.28M 14.56M 184M 13.86M 13.56M 582M 395K 278K 249K 229K 207K 387K 26.36M 2.73M 1.09M 13.87M 1.04M 1.02M 43.73M
Net Debt -14.18M -9.98M -8.93M -8.22M -7.45M -13.92M -947M -98M -39.34M -498M -37.44M -36.64M -1.57B -13.82M -9.72M -8.71M -8.01M -7.26M -13.57M -923M -95.52M -38.34M -486M -36.49M -35.71M -1.53B
Projected Income Statement - Annual - Star Combo Pharma Limited
Logo Star Combo Pharma Limited
Star Combo Pharma Limited is an Australia-based manufacturer and distributor of premium health and natural beauty products. The Company operates through two segments: the Star Combo business and the Austoyou retail business. The Star Combo business segment is engaged in the business of development, manufacturing, marketing and sales of natural health supplements and skin care products. The Austoyou retail business is made up of the Australia-China e-commerce platform that offers over 5,000 high-demand product lines directly to Chinese health product consumers. The Company’s product categories include Costar, Living Healthy, Amax, and J&K. The Company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance. The Company’s wholly owned subsidiaries include CoStar Pharma Laboratory Pty Ltd, Star Combo Australia Pty Ltd, Austoyou Group Pty Ltd, and Koala Mall Pty Ltd.
Employees
30
Date Price Change Volume
30/10/26 A$0.1400 -.--% 6,001